Affimed (NASDAQ: AFMD) reported Q1 EPS of (EUR1.27), EUR0.28 better than the analyst estimate of (EUR1.55). Revenue for the quarter came in at EUR155 thousand versus the consensus estimate of EUR425 thousand.

For earnings history and earnings-related data on Affimed (AFMD) click here.